TRIFERTY-ATM®
Not Specified
Co-development CompletedPre-registration/Launch Ready
Key Facts
Indication
Not Specified
Phase
Co-development Completed
Status
Pre-registration/Launch Ready
Company
About Laboratorio Reig Jofre
Founded in 1929, Laboratorio Reig Jofre is a publicly traded Spanish pharmaceutical company on a mission to 'universalize essential health solutions.' Its strategy is built on vertical integration, advanced sterile manufacturing capabilities, and proprietary drug delivery technologies like CicloTech®. Key achievements include strategic investments in biotech manufacturing (Leanbio), a European Commission vaccine capacity reservation, and a growing international commercial footprint across Europe and Asia.
View full company profileTherapeutic Areas
Other Not Specified Drugs
| Drug | Company | Phase |
|---|---|---|
| FL116 | Forlong Biotechnology | Not specified |
| FL117 | Forlong Biotechnology | Not specified |
| FL118 | Forlong Biotechnology | Not specified |
| FL301 | Forlong Biotechnology | Not specified |
| JSKN016 | AlphaMab Oncology | Phase 1 |
| JSKN033 | AlphaMab Oncology | Phase 1 |
| JSKN022 | AlphaMab Oncology | Phase 1 |
| JSKN027 | AlphaMab Oncology | Phase 1 |
| KN019 | AlphaMab Oncology | Phase 1 |
| New TCM Formulations | China SXT Pharmaceuticals | Research / Pre-clinical |
| Long-acting Leronlimab | CytoDyn | Preclinical |
| SR2162 | SIMR (Australia) Biotech | IND Approved |